ARCHIVES

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

This article is from The Cancer Letter archive.

Vol. 31 No. 10 | October 31, 2008

Download PDF Visit The Full Archive

Related Articles

NCI CTEP-Approved Trials For the Month of September

September 26, 2014

CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years

April 16, 1999

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

April 9, 2010

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

NCI To Offer Planning Grants for New Centers

November 9, 1990